Hantavirus (HV), a pathogen of animal infectious diseases that poses a threat to humans, has attracted extensive attention. Clinically, HV can cause hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS), between which HFRS is mostly in Eurasia, and HPS is mostly in the Americas. This paper reviews the research progress of small-molecule inhibitors of HV.

中文翻译：

---

开发针对汉坦病毒的小分子抑制剂。

汉坦病毒（HV）是一种动物传染病的病原体，对人类构成威胁，已引起广泛关注。在临床上，HV可引起肾综合征（HFRS）和汉坦病毒性肺综合征（HPS）出血热，其中HFRS主要发生在欧亚大陆，HPS主要发生在美洲。本文综述了小分子HV抑制剂的研究进展。